COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 1710: Articles 17091-17100  | Next

COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study
Hussein, N. R., Balatay, A., Naqid, I. A., Jamal, S. A., Rasheed, N. A., Ahmed, A. N., Salih, R. S., Mahdi, A. S., Mansour, S. A., Mahdi, S., Ibrahim, N., Musa, D. H., Saleem, Z. S.
10.1101/2021.03.23.21254169 — Posted: 2021-03-26
Impact of the COVID-19 Pandemic on Antimicrobial Resistance (AMR) Surveillance, Prevention and Control: A Global Survey
Tomczyk, S., Taylor, A., Brown, A., de Kraker, M., Eckmanns, T., El-Saed, A., Alshamrani, M., Hendriksen, R., Jacob, M., Lofmark, S., Perovic, O., Shetty, N., Sievert, D., Smith, R., Stelling, J., Thakur, S., Tornimbene, B., Vietor, A. C., Eremin, S., WHO AMR Surveillance and Quality Assessment Collaborating Centre Network
10.1101/2021.03.24.21253807 — Posted: 2021-03-26
A SIMPLE, HOME-THERAPY ALGORYTHM TO PREVENT HOSPITALIZATION OF COVID-19 PATIENTS: A RETROSPECTIVE OBSERVATIONAL MATCHED-COHORT STUDY
Suter, F., Consolaro, E., Pedroni, S., Moroni, C., Pasto, E., Paganini, M. V., Prevettoni, G., Cantarelli, U., Rubis, N., Perico, N., Perna, A., Peracchi, T., Ruggenenti, P., Remuzzi, G.
10.1101/2021.03.25.21254296 — Posted: 2021-03-26 Discussion: Onsite
Pooling-in-a-pod: A Strategy for COVID-19 Testing to Facilitate Safe Return to School
Berke, E. M., Newman, L. M., Jemsby, S., Bhalla, N., Sheils, N. E., Oomman, N., Reppas, J., Hyde, B., Verma, P., Cangelosi, G. A.
10.1101/2021.03.24.21254230 — Posted: 2021-03-26
Improving COVID-19 vaccination centre operation through computer modelling and simulation
Wood, R. M., Moss, S. J., Murch, B. J., Davies, C., Vasilakis, C.
10.1101/2021.03.24.21253517 — Posted: 2021-03-26
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males.
Croci, S., Venneri, M. A., Mantovani, S., Fallerini, C., Benetti, E., Picchiotti, N., Campolo, F., Imperatore, F., Palmieri, M., Daga, S., Gabbi, C., Montagnani, F., Beligni, G., Farias, T. D. J., Carriero, M. L., Di Sarno, L., Alaverdian, D., Aslaksen, S., Cubellis, M. V., Spiga, O., Baldassarri, M., Fava, F., Norman, P. J., Frullanti, E., Isidori, A. M., Amoroso, A., Mari, F., Furini, S., Mondelli, M., GEN-COVID Multicenter Study, , Chiariello, M., Renieri, A., Meloni, I.
10.1101/2021.03.23.21254158 — Posted: 2021-03-26
Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a fourplex real-time quantitative reverse transcription-PCR assays.
Durand, M., Thibault, P., Levesque, S., Brault, A., Carignan, A., Valiquette, L., Martin, P., Labbe, S.
10.1101/2021.03.23.21254196 — Posted: 2021-03-26
Endogenous interferon-beta but not interferon-alpha or interferon-lambda levels in upper respiratory tract predict clinical outcome in critical COVID-19 patients independent of viral load
MENEZES, S. M., Braz, M., Llorens-Rico, V., Wauters, J., Van Weyenbergh, J.
10.1101/2021.03.23.21253748 — Posted: 2021-03-26
Continuity of routine immunization programs in Canada during the COVID-19 pandemic
Sell, H., Assi, A., Driedger, M., Dube, E., Gagneur, A., Meyer, S. B., Robinson, J., Sadarangani, M., Tunis, M., MacDonald, S. E.
10.1101/2021.03.22.21254121 — Posted: 2021-03-26
Development of a Codebook of Online Anti-Vaccination Rhetoric to Manage COVID-19 Vaccine Misinformation
Hughes, B., Miller-Idriss, C., Piltch-Loeb, R., White, K., Criezis, M., Cain, C., Savoia, E.
10.1101/2021.03.23.21253727 — Posted: 2021-03-26 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).